Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Plasma cell 2Gynecologic 2Gastrointestinal 2Dermatologic 2Breast 2Thoracic 1Genitourinary 1

Conditions

Sarcoma, Kaposi 2Sarcoma 2

Interventions

Cyclophosphamide 54Specimen Handling 50Magnetic Resonance Spectroscopy 49pembrolizumab 43Doxorubicin 43Radiotherapy 42Temozolomide 37Biopsy 34Radiation 29Nivolumab 28fludarabine 23Vincristine 22Irinotecan 21Gemcitabine 21X-Rays 20Surgical Procedures, Operative 19Ifosfamide 19atezolizumab 17cabozantinib 15Ipilimumab 15olaparib 13Sunitinib 13Paclitaxel 13regorafenib 12fludarabine phosphate 12Phantoms, Imaging 12Imatinib Mesylate 12Etoposide 12Blood Specimen Collection 12Carboplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Propranolol × Sarcoma × 1 year × Clear all
NCT06445166 2026-04-06

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Washington University School of Medicine

Phase 2 Recruiting
25 enrolled
Sarcoma

Sarcoma, Sarcoma, Kaposi

NCT05797662 2026-01-23

A Study of Propranolol to Treat Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Not yet recruiting
25 enrolled
Sarcoma

Sarcoma, Kaposi

NCT06670976 2025-08-26

Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma

Roswell Park Cancer Institute

Phase 1 Withdrawn
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡